Nextage Therapeutics Ltd (NXTG)

Currency in ILS
99.7
0.0(0.00%)
Closed·
NXTG Scorecard
Full Analysis
Short term obligations exceed liquid assets
NXTG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
99.799.7
52 wk Range
0.8119.0
Key Statistics
Bid/Ask
90.00 / 99.70
Prev. Close
99.7
Open
99.7
Day's Range
99.7-99.7
52 wk Range
0.8-119
Volume
-
Average Volume (3m)
48.36K
1-Year Change
45.97%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NXTG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Not profitable over the last twelve months

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Nextage Therapeutics Ltd Company Profile

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products. The company was formerly known as Nextage Cannabis Innovation Ltd. and changed its name to Nextage Therapeutics Ltd in August 2020. The company was incorporated in 1982 and is based in Ness Ziona, Israel.

Compare NXTG to Peers and Sector

Metrics to compare
NXTG
Peers
Sector
Relationship
P/E Ratio
−10.2x−3.3x−0.5x
PEG Ratio
−0.41−0.030.00
Price/Book
-2.5x2.6x
Price / LTM Sales
81.3x7.8x3.2x
Upside (Analyst Target)
-511.5%40.5%
Fair Value Upside
Unlock17.8%4.4%Unlock

Earnings

Latest Release
Mar 26, 2023
EPS / Forecast
-0.10 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NXTG Income Statement

FAQ

What Stock Exchange Does Nextage Therapeutics Trade On?

Nextage Therapeutics is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Nextage Therapeutics?

The stock symbol for Nextage Therapeutics is "NXTG."

What Is the Nextage Therapeutics Market Cap?

As of today, Nextage Therapeutics market cap is 33.60M.

What Is Nextage Therapeutics's Earnings Per Share (TTM)?

The Nextage Therapeutics EPS (TTM) is -0.10.

From a Technical Analysis Perspective, Is NXTG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nextage Therapeutics Stock Split?

Nextage Therapeutics has split 2 times.

How Many Employees Does Nextage Therapeutics Have?

Nextage Therapeutics has 31 employees.

What is the current trading status of Nextage Therapeutics (NXTG)?

As of 25 Jul 2025, Nextage Therapeutics (NXTG) is trading at a price of 99.70, with a previous close of 99.70. The stock has fluctuated within a day range of 99.70 to 99.70, while its 52-week range spans from 0.80 to 119.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.